ATOSSA THERAPEUTICS, INC. Selling Expense
ATOSSA THERAPEUTICS, INC. (ATOS) reported Selling Expense of $0 for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2017-03-21
- ATOSSA THERAPEUTICS, INC. selling expense for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. selling expense for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. selling expense for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. selling expense for the quarter ending 2015-12-31 was $233.63K.
- ATOSSA THERAPEUTICS, INC. selling expense for fiscal 2015 was $1.42M, a 104.25% increase from fiscal 2014.
- ATOSSA THERAPEUTICS, INC. selling expense for fiscal 2014 was $695.93K, a 44.67% decline from fiscal 2013.
- ATOSSA THERAPEUTICS, INC. selling expense for fiscal 2013 was $1.26M, a 169.44% increase from fiscal 2012.
- ATOSSA THERAPEUTICS, INC. selling expense for fiscal 2012 was $466.82K, a 190.22% increase from fiscal 2011.
| Period end | Selling Expense 3 month | Selling Expense 3 month as first filed | Selling Expense 6 month | Selling Expense 6 month as first filed | Selling Expense 9 month | Selling Expense 9 month as first filed | Selling Expense 12 month | Selling Expense 12 month as first filed | Selling Expense 41 month | Selling Expense 44 month | Selling Expense 47 month | Selling Expense 50 month | Selling Expense 53 month | Selling Expense 56 month | Selling Expense 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | $233.63K derived: sum of 4 quarters · filed 2017-03-21 | |||||||||||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-12 | $0.00 10-Q · filed 2016-08-12 | $233.63K derived: sum of 3 quarters · filed 2017-03-21 | $732.24K derived: sum of 4 quarters · filed 2017-03-21 | |||||||||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | $233.63K derived: sum of 2 quarters · filed 2017-03-21 | $732.24K derived: sum of 3 quarters · filed 2017-03-21 | $1.08M derived: sum of 4 quarters · filed 2017-03-21 | |||||||||||
| 2015-12-31 | $233.63K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | $732.24K derived: sum of 2 quarters · filed 2017-03-21 | $1.08M derived: sum of 3 quarters · filed 2017-03-21 | $1.42M 10-K/A · filed 2017-03-21 | |||||||||||
| 2015-09-30 | $498.61K 10-Q/A · filed 2017-03-21 | $738.04K 10-Q · filed 2015-11-12 | $841.93K derived: sum of 2 quarters · filed 2017-03-21 | $1.19M 10-Q/A · filed 2017-03-21 | $2.02M 10-Q · filed 2015-11-12 | $1.14M derived: sum of 4 quarters · filed 2017-03-21 | |||||||||
| 2015-06-30 | $343.32K 10-Q/A · filed 2017-03-21 | $732.06K 10-Q · filed 2015-08-06 | $689.17K 10-Q/A · filed 2017-03-21 | $1.28M 10-Q · filed 2015-08-06 | $641.50K derived: sum of 3 quarters · filed 2017-03-21 | $923.87K derived: sum of 4 quarters · filed 2017-03-21 | |||||||||
| 2015-03-31 | $345.85K 10-Q/A · filed 2017-03-21 | $546.85K 10-Q · filed 2015-05-13 | $298.18K derived: sum of 2 quarters · filed 2017-03-21 | $580.55K derived: sum of 3 quarters · filed 2017-03-21 | $803.94K derived: sum of 4 quarters · filed 2017-03-21 | ||||||||||
| 2014-12-31 | -$47.67K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $234.71K derived: sum of 2 quarters · filed 2016-03-30 | $458.09K derived: sum of 3 quarters · filed 2016-03-30 | $695.93K 10-K · filed 2016-03-30 | $1.27M 10-K · filed 2015-03-30 | ||||||||||
| 2014-09-30 | $282.37K 10-Q · filed 2015-11-12 | $505.76K derived: sum of 2 quarters · filed 2015-11-12 | $743.60K 10-Q · filed 2015-11-12 | $1.04M derived: sum of 4 quarters · filed 2015-11-12 | |||||||||||
| 2014-06-30 | $223.38K 10-Q · filed 2015-08-06 | $461.22K 10-Q · filed 2015-08-06 | $753.63K derived: sum of 3 quarters · filed 2015-08-06 | $1.13M derived: sum of 4 quarters · filed 2015-08-06 | |||||||||||
| 2014-03-31 | $237.84K 10-Q · filed 2015-05-13 | $530.25K derived: sum of 2 quarters · filed 2015-05-13 | $903.66K derived: sum of 3 quarters · filed 2015-05-13 | $1.22M derived: sum of 4 quarters · filed 2015-05-13 | $2.14M 10-Q · filed 2014-05-14 | ||||||||||
| 2013-12-31 | $292.41K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $665.83K derived: sum of 2 quarters · filed 2015-03-30 | $985.22K derived: sum of 3 quarters · filed 2015-03-30 | $1.26M 10-K · filed 2015-03-30 | $1.90M 10-K · filed 2014-03-27 | ||||||||||
| 2013-09-30 | $373.42K 10-Q · filed 2014-11-12 | $692.81K derived: sum of 2 quarters · filed 2014-11-12 | $965.38K 10-Q · filed 2014-11-12 | $1.15M derived: sum of 4 quarters · filed 2014-11-12 | $1.61M 10-Q · filed 2013-11-12 | ||||||||||
| 2013-06-30 | $319.39K 10-Q · filed 2014-08-12 | $591.97K 10-Q · filed 2014-08-12 | $776.82K derived: sum of 3 quarters · filed 2014-08-12 | $864.52K derived: sum of 4 quarters · filed 2014-08-12 | $1.23M 10-Q · filed 2013-08-14 | ||||||||||
| 2013-03-31 | $272.57K 10-Q · filed 2014-05-14 | $457.43K derived: sum of 2 quarters · filed 2014-05-14 | $545.13K derived: sum of 3 quarters · filed 2014-05-14 | $668.96K derived: sum of 4 quarters · filed 2014-05-14 | $912.45K 10-Q · filed 2013-05-15 | ||||||||||
| 2012-12-31 | $184.85K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $272.55K derived: sum of 2 quarters · filed 2014-03-27 | $396.39K derived: sum of 3 quarters · filed 2014-03-27 | $466.82K 10-K · filed 2014-03-27 | $639.88K 10-K · filed 2013-03-28 | ||||||||||
| 2012-09-30 | $87.70K 10-Q · filed 2013-11-12 | -$87.70K 10-Q/A · filed 2013-01-22 | $211.54K derived: sum of 2 quarters · filed 2013-11-12 | $281.97K 10-Q · filed 2013-11-12 | -$281.97K 10-Q/A · filed 2013-01-22 | $442.82K derived: sum of 4 quarters · filed 2013-11-12 | -$455.03K 10-Q/A · filed 2013-01-22 | ||||||||
| 2012-06-30 | $123.83K 10-Q · filed 2013-08-14 | $194.27K 10-Q · filed 2013-08-14 | $355.12K derived: sum of 3 quarters · filed 2013-08-14 | $355.12K derived: sum of 4 quarters · filed 2013-08-14 | |||||||||||
| 2012-03-31 | $70.44K 10-Q · filed 2013-05-15 | $231.29K derived: sum of 2 quarters · filed 2013-05-15 | $231.29K derived: sum of 3 quarters · filed 2013-05-15 | ||||||||||||
| 2011-12-31 | $160.85K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | $160.85K derived: sum of 2 quarters · filed 2013-03-28 | $160.85K 10-K · filed 2013-03-28 | ||||||||||||
| 2011-09-30 | $0.00 10-Q/A · filed 2013-01-22 | $0.00 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |